Page 285 - Crisil Annual Report 2023

Financial Statements
Standalone
Transactions with related parties
CRISIL Irevna US LLC
Professional services rendered
Billing done on behalf of Company
Professional fees paid
Support and management fee
Reimbursement of expenses received
Reimbursement of expenses paid
Sale of property, plant and equipment
Transfer of employee related liabilities
Reimbursement of expense received (ESOS)
Amount received by CRISIL on behalf of Irevna US
Amount received by Irevna US on behalf of CRISIL
Amount payable (net)
Professional fees paid
Amount payable
Professional fees paid
Investment outstanding
Amount payable
Dividend income
Professional fees paid
Investment outstanding
Amount payable
Professional services rendered
Support and management fee
Transfer of project cost
Reimbursement of expense received (ESOS)
Reimbursement of expense received
Sale of property, plant and equipment
Amount receivable
Reimbursement of expense received (ESOS)
Professional fees paid
Sale of property, plant and equipment
Amount payable
Donation
Amount received by CRISIL on behalf of CRISIL foundation
Loan given
Loan repaid
Interest income
Reimbursement of expense received Amount receivable
(C lakh)
2,302 770 13,243 2,483 365 622 1 - -*
-
-
1,595 1,779 131 4,255 147 976 232 2,935 244 335 8,505 1,453 - (26)
3
1 850 (6)
478 -
63 703 -
110 110 -* 67 80
Name of the related party
Nature of transaction / outstanding balances
As at and for the year ended December 31, 2023
As at and for the year ended December 31, 2022
3,344
55
13,457
2,472
41
623
1
63
-
65
1,981
718
1,888
189
2,683
147
418
284
3,393
244
290
9,361
1,659
1,450
-
-
-
3,154
-
482
-*
64
495
2
350
350
7
113
143
CRISIL Irevna Poland Sp.zo.o CRISIL Irevna Argentina, S.A.
CRISIL Irevna Information & Technology (Hangzhou) Co. Limited
Coalition Development Limited
Coalition Development Singapore Pte Limited
CRISIL Foundation
Annual Report 2023
283